WorldPharmaNews
  • Home
  • Business
  • Research
  • Jobs
  • Events
  • Regulatory

Sanofi and Astellas to dissolve sanofi-aventis Yamanouchi Pharmaceutical Inc.

Details
Business
29 February 2012
Astellas Pharma Inc.Sanofi and Astellas Pharma Inc. announced that the two companies agreed to dissolve sanofi-aventis Yamanouchi Pharmaceutical Inc., a joint company of Sanofi and Astellas.
Read more ...

Forest Laboratories Completes Acquisition of Clinical Data, Inc.

Details
Business
14 April 2011
Forest LaboratoriesForest Laboratories, Inc. (NYSE: FRX) ("Forest") has successfully completed its acquisition of Clinical Data, Inc. (NASDAQ: CLDA) ("Clinical Data") by means of what is known as a short-form merger under Delaware law.
Read more ...

Forest Laboratories, Inc. Finalizes Previously Disclosed Settlement of U.S. Government Investigations

Details
Business
16 September 2010
Forest Laboratories, Inc.Forest Laboratories, Inc. (NYSE: FRX) has finalized a previously reported agreement-in-principle to resolve all aspects of the investigations led by the United States Department of Justice (DOJ) and the United States Attorney's Office for the District of Massachusetts that began in January 2004 relating to past marketing, sales, and other activities in connection with Celexa(R), Lexapro(R), and a formulation of Levothroid(R) that Forest ceased distributing in 2003.
Read more ...

Covex S.A. creates 2000 jobs with the onset of a new agroindustrial project in Latin America

Details
Business
17 May 2010
Covex S.A.Covex S.A., leader in the manufacture of products aimed at improving cerebral functions, successfully reaches the first stage of its introduction in Latin America, as it begins to harvest medicinal plants on an industrial scale, for the onset of its new agroindustrial expansion.
Read more ...

Luitpold Pharmaceuticals, Inc. Acquires PharmaForce, Inc.

Details
Business
06 January 2010
Daiichi Sankyo Co., Ltd.Luitpold Pharmaceuticals, Inc., a New York based U.S. Company of Daiichi Sankyo Co., Ltd. (Corporate Headquarters: Tokyo, Japan) and PharmaForce, Inc., (Columbus, Ohio, USA), a privately-held fullyintegrated specialty injectable pharmaceutical company, announced today that PharmaForce has been acquired by Luitpold.
Read more ...

Onyx Pharmaceuticals to Acquire Proteolix, Inc.

Details
Business
12 October 2009
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has signed a definitive agreement to acquire Proteolix, Inc., a privately held biopharmaceutical company focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors.
Read more ...

Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Next Generation Anti-Infective

Details
Business
13 August 2009
Forest LaboratoriesForest Laboratories (NYSE:FRX) and AstraZeneca (NYSE:AZN) have entered into a definitive collaboration agreement to co-develop and commercialize ceftaroline in all markets outside the United States, Canada and Japan. Ceftaroline is Forest's late stage, next generation cephalosporin being investigated for the treatment of complicated skin and skin structure infections (cSSSI) and community-acquired bacterial pneumonia (CABP).
Read more ...

More Pharma News ...

  1. Schering-Plough announces collaboration with World Health Organization
  2. DHL COLDCHAIN offers fast, reliable and flexible solutions designed for the Life Science Industry
  3. FivePrime and Pfizer Enter Oncology and Diabetes Collaboration
  4. Grindeks JSC is opening new representative office in Uzbekistan
  5. Dr. Reddy's acquires Jet Generici Srl. Acquisition to establish Generics business in Italy
  6. Aurobindo Pharma expands in Europe
  7. Baxter and its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
  • End
admet_300x250

Business & Industry

  • FDA grants Breakthrough Therapy Designation for Roche's Hemlibra in haemophilia A without inhibitors
  • Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials
  • Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford
  • Bristol-Myers Squibb announces worldwide collaboration with Janssen to develop and commercialize next-generation cardiovascular therapy
  • GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics

Research & Development

  • Personalized tumor vaccine shows promise in pilot trial
  • New class of drugs could help tackle treatment-resistant cancers
  • New immunotherapy for lung cancer shows promise of success
  • Human drug trials are compromised by poor reporting of animal research
  • 'Coffee filter' helps make new cancer drug Z-endoxifen 1,000 times cheaper
  • Researchers propose key elements of antimicrobial stewardship for hospitals worldwide
  • When drugs are wrong, skipped or make you sick: The cost of non-optimized medications

Conferences & Events

  • SMi presents the 2nd annual conference on Pharmaceutical Microbiology West Coast
  • Introducing SMi's 6th annual conference on Pharmaceutical Freeze Drying Technology this June 2018
  • Adaptive Designs in Clinical Trials Conference 2018
  • Drug Safety 2018
  • Controlled Release Delivery Conference 2018
  • Superbugs & Superdrugs Conference 2018
  • Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference 2018

Regulatory Affairs

  • FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
  • FDA approves new treatment for certain digestive tract cancers
  • FDA approves first treatment for breast cancer with a certain inherited genetic mutation
  • FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response
  • FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
  • FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care
  • FDA launches public education campaign to encourage adult smokers trying to quit cigarettes
  1. You are here:  
  2. Home
  3. Business

About

  • Home
  • Advertise
  • Privacy
  • Terms of Use
  • Contact

Submit Your News!

Latest WORLD PHARMA JOBS

  • Senior Clinical Data Manager
  • Director Technology Strategy and Innovation

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2006 - 2017. All Rights Reserved. Our top projects: World Pharma News | WORLD PHARMA JOBS | PharmaNews.eu | eHealthNews.eu | (HEALTH IT) SPACE